422
Views
5
CrossRef citations to date
0
Altmetric
Neurotherapeutics

Health care resource use analysis of paliperidone palmitate 3 month injection from two phase 3 clinical trials

, &
Pages 1083-1090 | Received 05 Dec 2016, Accepted 23 Feb 2017, Published online: 28 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maju Mathews, Srihari Gopal, Isaac Nuamah, Ludger Hargarter, Adam J Savitz, Edward Kim, Wilson Tan, Bernardo Soares & Christoph U Correll. (2019) Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 1365-1379.
Read now
Alicia Lopez & Jose Rey. (2019) Role of paliperidone palmitate 3-monthly in the management of schizophrenia: insights from clinical practice. Neuropsychiatric Disease and Treatment 15, pages 449-456.
Read now
Claudio Brasso, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni & Paola Rocca. (2017) Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia. Neuropsychiatric Disease and Treatment 13, pages 2767-2779.
Read now

Articles from other publishers (2)

Juan Antonio García-Carmona, Joshua Barnett, María Pilar Campos-Navarro, Katy Mason, Francisco Valdivia-Muñoz & Sofia Pappa. (2022) Comparative effectiveness of long-acting injectable antipsychotics in a large naturalistic cohort across two European centers: Findings from the long-acting injectable antipsychotics collaborative (LAICO) study.. Neuroscience Applied 1, pages 100111.
Crossref
Amber N. Edinoff, Prithvi K. Doppalapudi, Claudia Orellana, Caroline Ochoa, Shelby Patti, Yahya Ghaffar, Elyse M. Cornett, Aaron J. Kaye, Omar Viswanath, Ivan Urits, Adam M. Kaye & Alan D. Kaye. (2021) Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review. Frontiers in Psychiatry 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.